Robert J Valuck

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint Enhancing electronic health record measurement of depression severity and suicide ideation: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study
    Robert J Valuck
    Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, the American Academy of Family Physicians, Denver, CO, USA
    J Am Board Fam Med 25:582-93. 2012
  2. doi request reprint Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study
    Robert J Valuck
    School of Pharmacy, Anschutz Medical Campus at Fitzsimons, University of Colorado Denver, PO Box 6508, Aurora, CO 80045, USA
    J Clin Psychiatry 70:1069-77. 2009
  3. ncbi request reprint Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs
    Robert J Valuck
    University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    Am J Psychiatry 164:1198-205. 2007
  4. ncbi request reprint Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs
    Elaine H Morrato
    University of Colorado, Denver, CO 80262, USA
    Am J Psychiatry 165:42-50. 2008
  5. ncbi request reprint Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population
    David L McClure
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80237 8066, USA
    J Clin Epidemiol 60:812-8. 2007
  6. doi request reprint Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
    Arch Gen Psychiatry 67:17-24. 2010
  7. doi request reprint Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
  8. doi request reprint Metabolic screening in children receiving antipsychotic drug treatment
    Elaine H Morrato
    Department of Health Systems, Management, and Policy, Colorado School of Public Health, University of Colorado at Denver, Aurora, Colorado 80045, USA
    Arch Pediatr Adolesc Med 164:344-51. 2010
  9. doi request reprint Persisting decline in depression treatment after FDA warnings
    Anne M Libby
    School of Public Health, University of Colorado Denver, 13055 E 17th Ave, Nighthorse Campbell Native Health Building, Campus Box F800, Aurora, CO 80045, USA
    Arch Gen Psychiatry 66:633-9. 2009
  10. doi request reprint Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study
    Heather D Anderson
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver, CO, USA
    Clin Ther 34:113-23. 2012

Detail Information

Publications24

  1. doi request reprint Enhancing electronic health record measurement of depression severity and suicide ideation: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study
    Robert J Valuck
    Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, the American Academy of Family Physicians, Denver, CO, USA
    J Am Board Fam Med 25:582-93. 2012
    ..Clinical decision making and comparative studies of real-world antidepressant effectiveness are limited by the absence of clinical measures of severity of illness and suicidality...
  2. doi request reprint Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study
    Robert J Valuck
    School of Pharmacy, Anschutz Medical Campus at Fitzsimons, University of Colorado Denver, PO Box 6508, Aurora, CO 80045, USA
    J Clin Psychiatry 70:1069-77. 2009
    ..Gaps remain in understanding risks associated with antidepressant discontinuation in the context of the drug regimen. We assessed the effects of antidepressant discontinuation on the risk of suicide attempt...
  3. ncbi request reprint Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs
    Robert J Valuck
    University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    Am J Psychiatry 164:1198-205. 2007
    ..The authors examine the effects of this pediatric policy on treatment of adult depression in the community...
  4. ncbi request reprint Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs
    Elaine H Morrato
    University of Colorado, Denver, CO 80262, USA
    Am J Psychiatry 165:42-50. 2008
    ..In this study, the authors compared trends in the frequency of provider contacts for patients with depression before and after the advisory was issued...
  5. ncbi request reprint Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population
    David L McClure
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80237 8066, USA
    J Clin Epidemiol 60:812-8. 2007
    ..We quantified the risk of myositis associated with statin and fibrate drug use with other covariates within a managed care organization (MCO) population...
  6. doi request reprint Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
    Arch Gen Psychiatry 67:17-24. 2010
    ..The American Diabetes Association (ADA) and American Psychiatric Association (APA) recommended glucose and lipid testing for all patients starting to receive SGA drugs...
  7. doi request reprint Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
    ..We estimated glucose and lipid testing rates among SGA-users from three state Medicaid programs and investigated small area variation and patient and geographic determinants of testing...
  8. doi request reprint Metabolic screening in children receiving antipsychotic drug treatment
    Elaine H Morrato
    Department of Health Systems, Management, and Policy, Colorado School of Public Health, University of Colorado at Denver, Aurora, Colorado 80045, USA
    Arch Pediatr Adolesc Med 164:344-51. 2010
    ..To estimate metabolic screening rates, predictors of screening, and incidence of metabolic disturbances in children initiating second-generation antipsychotic (SGA) drug treatment...
  9. doi request reprint Persisting decline in depression treatment after FDA warnings
    Anne M Libby
    School of Public Health, University of Colorado Denver, 13055 E 17th Ave, Nighthorse Campbell Native Health Building, Campus Box F800, Aurora, CO 80045, USA
    Arch Gen Psychiatry 66:633-9. 2009
    ....
  10. doi request reprint Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study
    Heather D Anderson
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver, CO, USA
    Clin Ther 34:113-23. 2012
    ..There is a gap in knowledge of the prevalence of side effects across commonly prescribed antidepressants and the effect of the type of antidepressant on the likelihood of side effects in real-world clinical practice...
  11. ncbi request reprint How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs
    Robert J Valuck
    University of Colorado at Denver and Health Sciences Center, School of Pharmacy, Denver, CO 80262, USA
    Curr Med Res Opin 23:2567-76. 2007
    ..To characterize healthcare costs associated with antipsychotic polypharmacy and to investigate predictors of high-cost patients...
  12. ncbi request reprint Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado at Denver, Aurora, CO 80045 0508, USA
    J Clin Psychiatry 69:316-22. 2008
    ..This study aimed to determine the prevalence of serum glucose and lipid monitoring in public mental health clients initiating second-generation antipsychotic (SGA) drugs...
  13. ncbi request reprint Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study
    Robert J Valuck
    Department of Clinical Pharmacy, School of Pharmacy, University of Colorado, Denver, Colorado 80262, USA
    CNS Drugs 18:1119-32. 2004
    ..A large database of paid health insurance claims for adolescents with MDD provided the opportunity to examine this possible relationship...
  14. doi request reprint Comparative effectiveness research in DARTNet primary care practices: point of care data collection on hypoglycemia and over-the-counter and herbal use among patients diagnosed with diabetes
    Anne M Libby
    University of Colorado School of Pharmacy, Denver, CO, USA
    Med Care 48:S39-44. 2010
    ..DARTNet links information from nonintegrated primary care clinics that use EHRs to deliver ambulatory care to overcome limitations with traditional observational research...
  15. ncbi request reprint Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs
    Anne M Libby
    University of Colorado at Denver and Health Sciences Center, School of Medicine, Nighthorse Campbell Native Health Building, PO Box 6508, Campus Box F800, Aurora, CO 80045 0508, USA
    Am J Psychiatry 164:884-91. 2007
    ....
  16. ncbi request reprint Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Management and Policy, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
    ..We estimated glucose and lipid testing rates among SGA-users from three state Medicaid programs and investigated small area variation and patient and geographic determinants of testing...
  17. ncbi request reprint An electronic practice-based network for observational comparative effectiveness research
    Wilson D Pace
    University of Colorado Denver, School of Medicine, Aurora, Colorado 80045 0508, USA
    Ann Intern Med 151:338-40. 2009
    ....
  18. ncbi request reprint Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003
    Elaine H Morrato
    Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Clin Ther 29:183-95. 2007
    ....
  19. doi request reprint Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States
    Julia F Slejko
    Department of Clinical Pharmacy, Center for Pharmaceutical Outcomes Research, University of Colorado Aschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO 80045, USA
    Res Social Adm Pharm 9:108-13. 2013
    ..Evidence is missing on showcasing current practices of degree programs specific to the field of pharmaceutical outcomes research...
  20. doi request reprint Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV
    Kevin C Henderson
    1 University of Colorado Denver School of Pharmacy, Aurora, Colorado, USA
    AIDS Patient Care STDS 25:221-8. 2011
    ..10), but no statistically significant improvement in CD4 cell count. Clinical pharmacy interventions improved overall adherence to ART regimens in these patients with HIV...
  21. ncbi request reprint Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present
    David L McClure
    Kaiser Foundation Health Plan of Colorado, Clinical Research Unit, Denver, CO 80237 8066, USA
    Pharmacoepidemiol Drug Saf 16:132-43. 2007
    ..Our objective was to determine the association of clinically relevant adverse events from a systematic review and meta-analysis of statin randomized controlled trials (RCT)...
  22. ncbi request reprint A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults
    Robert J Valuck
    School of Pharmacy, University of Colorado Health Sciences Center, 4200 E 9th Ave, C 238, Denver, CO 80262, USA
    J Clin Epidemiol 57:422-8. 2004
    ..The purpose of this study was to examine the possible association between use of prescription histamine H-2 receptor antagonists (H2RA) or proton pump inhibitors (PPI) and vitamin B(12) deficiency in older adults...
  23. ncbi request reprint A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization
    Robert J Valuck
    University of Colorado Health Sciences Center, School of Pharmacy, Denver, Colorado 80262, USA
    Clin Ther 25:2936-57. 2003
    ..Few studies have examined the effectiveness of statins in a managed care setting...
  24. ncbi request reprint Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease
    Kavita V Nair
    University of Colorado Health Sciences Center, School of Pharmacy, 4200 East Ninth Ave, Box C 238, Denver, CO 80262, USA
    J Manag Care Pharm 9:123-33. 2003
    ..To evaluate the impact of 3-tier (copayment) pharmacy benefit structures on medication utilization behavior...